COVID-19: Customer information regarding product availability and ongoing service support
Roche is a global pioneer in pharmaceuticals and diagnostics. Our ultimate aim is to detect illnesses – such as cancer, infectious and cardiovascular disease – early, and to treat them with life-saving and life-changing medicines.
- In 2017 Roche invested 388m pounds in UK R&D and conducted 181 clinical trials1
- More than 519 million Roche diagnostic tests were carried out, and more than 700,000 people benefited from our medicines in the UK during 20171
- We contributed £1.2 billion in UK GDP and supported 16,600 UK jobs1
- Since 2012, Roche has reduced its impact on the UK environment, reducing CO2 emissions per employee by 35%1
We believe that good health is incredibly precious, but also complex, because every person is unique. We are working to advance the concept of ‘personalised healthcare’ – to transform people’s lives by delivering care tailored to each individual – helping to prevent, diagnose and treat illnesses more effectively.
We have extraordinary people making all this happen. We are the largest biotechnology company in the world. In the UK, we employ more than 2,100 people of 53 different nationalities across our pharmaceutical, diagnostic and diabetes care divisions, with a further 40+ employees working in our diagnostics division in Ireland. Diversity, inclusion and collaboration are in our DNA.
Our people are dedicated to making a difference to the lives of millions, by transforming science into breakthrough medicines and diagnostics.
The UK plays an important role in the global research and development (R&D) network for Roche. This includes research at our campus in Welwyn Garden City, as well as clinical trials carried out by external research organisations and collaborations with academic institutions and other partners.
As a result of our continued investment in R&D across the globe, we supply 581 different diagnostic tests to the UK, and since 2010, we have delivered eight new medicines, found new ways to use existing medicines across 12 different disease areas, and developed 10 new treatments to help people manage their diabetes.2
1. Roche Impact Report, data on file, September 2018
2. Data on file, September 2018